Joint Corp (JYNT) is Reiterated by Maxim Group to Buy, Lowers Price Target to $ 5

Joint Corp (JYNT) was Reiterated by Maxim Group to “Buy” while Lowering the Price Target of the company shares to $ 5 from a previous price target of $8 . Maxim Group advised their investors in a research report released on Jul 1, 2016.

Many Wall Street Analysts have commented on Joint Corp. Joint Corp was Downgraded by Feltl & Co. to ” Buy” on Jun 24, 2016.

Joint Corp closed down -0.14 points or -6.22% at $2.11 with 1,02,904 shares getting traded on Wednesday. Post opening the session at $2.25, the shares hit an intraday low of $2.1 and an intraday high of $2.29 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

In a different news, on Jun 29, 2016, David M Orwasher (Former Chief Dev/Strat Officer) sold 10,000 shares at $2.31 per share price. According to the SEC, on Mar 30, 2016, Ronald V Davella (director) purchased 3,000 shares at $3.14 per share price. On Mar 28, 2016, John B Richards (CEO) purchased 3,295 shares at $2.98 per share price, according to the Form-4 filing with the securities and exchange commission.

The Joint Corp. is a franchisor and an operator of chiropractic clinics that uses a private pay non-insurance cash-based model. The Company is engaged in franchising chiropractic clinics selling regional developer rights and supporting the operations of franchised chiropractic clinics at locations throughout the United States. Its clinics offer membership and wellness packages. The Company’s patients arrive at its clinics without appointments. Once a patient has joined the Company’s system and is returning for treatment they swipe their membership card at a card reader at the reception desk to announce their arrival. The patient is then escorted to an open adjustment area where they are required to remove their outerwear to receive their adjustment. Each patient’s records are digitally updated for ready retrieval in the Company’s data storage system by its chiropractors in compliance with all applicable medical records security and privacy regulations.

Joint Corp

Leave a Reply

Joint Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Joint Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.